Robert M. Jacobson, M.D. Department of Pediatric and Adolescent Medicine Mayo Clinic, Rochester, Minnesota
|
|
- Briana Stone
- 6 years ago
- Views:
Transcription
1 How to Conduct a Systematic Review: A Workshop 24 th Annual Primary Care Research Methods & Statistics Conference, San Antonio, Texas Saturday, December 3, 2011 Robert M. Jacobson, M.D. Department of Pediatric and Adolescent Medicine Mayo Clinic, Rochester, Minnesota Paul M. Darden, M.D. Department of Pediatrics University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma (A) systematic review is an overview of primary studies which contains an explicit statement of objectives, materials, and methods and has been conducted according to explicit and reproducible methodology. Trisha Greenhalgh By providing a reliable synthesis of the available evidence on a given topic, systematic reviews adhere to the principle that science is cumulative and facilitate decisions considering all the evidence on the effect of an intervention. The Cochrane Handbook A systematic review is a standardized and objective review as opposed to the more traditional narrative review. A systematic review does not necessarily include a meta-analyses, which is a mathematical combining of the results of two or more primary studies. The primary studies do not have to be randomized controlled trials. Standards exist for conducting systematic reviews of observational studies, including studies that answer questions other than therapeutic ones. This workshop focuses on the process of conducting a systematic review rather than their value and place in patient-centered research. Table of Contents Page Steps in Creating a Systematic Review 2 Define the Review Question and Develop Criteria for Including Studies 2 Search for Studies 2 Select Studies and Collect Data 3 Assess Risk of Bias in Included Studies 3 The Cochrane Collaboration s Tool for Assessing Risk of Bias 4 Analyze Data and Undertake Meta-Analyses 5 Address Reporting Biases 5 Assemble Results 6 An Example of a Summary of Findings Table 7 Interpret Results and Draw Conclusions 8 PRISMA Flow Chart 9 PRISMA Checklist 9 The Cochrane Collaboration 11 Selected Readings 11 1
2 Steps in Creating a Systematic Review 1) Define the review question and develop criteria for including studies 2) Search for studies 3) Select studies and collect data 4) Assess risk of bias in included studies 5) Analyze data and undertake meta-analyses 6) Address reporting biases 7) Assemble results 8) Interpret results and draw conclusions Define the Review Question and Develop Criteria for Including Studies Stating your research question and selection criteria first before gathering data maintains your systematic review as a means for hypothesis testing. To engage the resources of the Cochrane Collaboration, you must contact the organization and agree on a review topic with a Cochrane Review Group (CRG). The Cochrane Collaboration has 52 CRGs, each with their own scope. Many CRGs have priorities for reviews of importance and will require the completion of a title registration form. A systematic review begins with the development of an answerable question. The question should have a PICO framework. The question should specify the Population or Participants or Patients, the Interventions and Comparisons, and the Outcomes. Several but not many outcomes should be included both beneficial and harmful (in the case of a therapeutic intervention). On the other hand the outcomes should be clinically meaningful and not trivial. The PICO question will drive both the detailed criteria for including studies and excluding others as well as the literature search itself. Exercise 1 Consider the postcard reminders veterinarians use to remind their clients of their pet s vaccinations that are coming due. Do you think they might work for humans? Write a PICO question and then draft a specific list of inclusion and exclusion criteria. Search for Studies Create a protocol for the search that includes three aspects 1) systematic of multiple, electronic databases, 2) a review of the reference lists of published studies found, and 3) consultation with experts. Use the PICO question to identify the key terms for your search. Usually use P and I connected by the Boolean Operator AND. Avoid using too many search concepts such as P, I, C, and O all at once. Identify synonyms for each of the terms to broaden the search. Goal is high sensitivity and low specificity. Use OR to link synonyms. Use free text as well as subject heading (MeSH or Medical Subject Headings). Use multiple electronic databases (MEDLINE or Pubmed for NLM, CINAHL for the nursing literature, EMBASE for Elsevier s database, PsychLit, Sociological Abstracts, CABHealth, 2
3 HealthSTAR, AIDSlINE, Occupational Safety and Health Database, Educational Research Index (ERIC), PsycINFO, Dissertation Abstracts, and Conference Papers Index). Google Scholar can provide access to the gray literature to generate reference lists. Goal is to include studies (rather than reports of studies) but the majority of studies are identified through the published reports. One can identify studies, if they are clinical trials, through trial registries as well. In this way, one can find trials that have not yet been published either because they are still underway or because the investigators chose not to publish them. Those working with the Cochrane Collaboration will be able to access the Cochrane Central Register of Controlled Trials (CENTRAL). Filters can be used to seek randomized trials. These are often specific to the database, however. For example, in PubMed, you can select limits to only include types of articles that are randomized controlled trials. Exercise 2 Using the agreed upon PICO question, design a search strategy complete with synonyms for a generic, electronic database. Select Studies and Collect Data These two tasks can be done simultaneously. Use at least two abstractors working independently. The team can use consensus to resolve differences between reviewers. Use a standardized abstraction form to evaluate each eligible study. The data collection form is key. Design it carefully to target the objectives of the systematic review. Pilot the form before launching the abstraction efforts. See the Zaza 2000 citation for detailed instructions as well as an example. Again, the unit of measure is the study and not the report. Abstractors must carefully recognize and connect studies that are reported more than once. The PRISM Flow Chart describes the flow of information through the different phases of a systematic review Assess Risk of Bias in Included Studies Conducting a systematic review requires that you not only collect appropriate studies but you assess them for bias. The inclusion and exclusion criteria took care of issues with generalizability (external reliability) but not with (bias) internal validity. You will want to use a standardized approach to assess risk of bias of individual studies You should also decide a priori how your assessment of bias for an individual study will affect how you report the results and use it for any data synthesis. You can choose from a variety of sources to obtain tools to assess the methodological quality of the studies. Avoid the temptation to use a numerical scale. You need a clear useful categorization of the studies. The Cochrane Collaboration prefers assessments of low risk, high risk, or unclear risk of bias. For parallel group trials, the Cochrane Collaboration asks for assessments of bias with regard to the following: 3
4 Sequence generation Allocation sequence concealment Blinding Incomplete outcome data Selective outcome reporting Assessments should include consideration of the effect of the bias in terms of over- or underestimating the true outcomes. Exercise 3 Listen to the reading of the methods of one of the selected studies and make the assessment using the following bias assessment tool: The Cochrane Collaboration s Tool for Assessing Risk of Bias Domain Description Review authors judgement Sequence generation. Describe the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. Was the allocation sequence adequately generated? Allocation concealment. Blinding of participants, personnel and outcome assessors Assessments should be made for each main outcome (or class of outcomes). Incomplete outcome data Assessments should be made for each main outcome (or class of outcomes). Selective outcome reporting. Describe the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment. Describe all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Provide any information relating to whether the intended blinding was effective. Describe the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis. State whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomized participants), reasons for attrition/exclusions where reported, and any re-inclusions in analyses performed by the review authors. State how the possibility of selective outcome reporting was examined by the Was allocation adequately concealed? Was knowledge of the allocated intervention adequately prevented during the study? Were incomplete outcome data adequately addressed? Are reports of the study free of suggestion of selective outcome 4
5 Other sources of bias. review authors, and what was found. State any important concerns about bias not addressed in the other domains in the tool. If particular questions/entries were prespecified in the review s protocol, responses should be provided for each question/entry. reporting? Was the study apparently free of other problems that could put it at a high risk of bias? Analyze Data and Undertake Meta-Analyses A meta-analysis is the statistical combination of results from two or more studies. Such a combination can improve power to rule out a Type II error, provide improved precision to an outcome estimate, or address questions in subgroups not addressed in individual studies. On the other hand, a poorly done meta-analysis can incorrectly combine studies that should not be combined and drown important differences in a statistical pool. (Alvan R Feinstein) Not every systematic review permits a meta-analysis but when it is appropriate one should be conducted. The Cochrane Collaboration provides free software to download from the internet to combine studies. The software is called RevMan. Most statistical approaches to combining the results use a system of sample-size weighting of the effect size estimates from the individual studies. Studies that test as homogeneous can be combined and permit fixed-effects meta-analyses. Random effects meta-analyses permit combining heterogeneous studies but care must be taking in their interpretation. Sensitivity analyses can help in the evaluation of the results of a meta-analysis to determine how robust the results are. Sensitivity analyses may include fixed effects versus random effects analyses, methodological quality, inclusion/exclusion of unpublished studies, and characteristics of the intervention or study population. Choose outcomes to combine that are suitable for comparing intervention groups. For clinically relevant Numbers Needed to Treat calculations select outcomes where the patient or participant count forms the denominator. End points such as time to recovery or frequency of events lack the same clinical relevance. Exercise 4 As a large group, we will test a number of studies to combine first for heterogeneity and finding none, we will combine them using the Mantel-Haenzel Chi Square approach (a fixed effects method). Address Reporting Biases Reporting biases occur when the dissemination of a study s results are affected by the direction and magnitude of a study s results. Reporting biases include publication, time-lag, multiple publication, citation, and language biases. Investigations have shown that while there really appears to be a tendency for negative studies not to appear in the published literature, the fault appears to lay in the investigators efforts rather than the editors or peer-reviewers. 5
6 Not studied is the differential in availability by systematic searches depending on the journal that publishes the report of the study. However, a priori trial registries and changes in understanding of the need to publish small, equivocal studies are improving the situation. In conducting a systematic review, you must assess and addressing reporting biases. A funnel plot is a scatter plot of treatment effect against a measure of study size (such as standard error of the treatment effect). In general if all studies regarding a common treatment effect are published without bias to either the statistical significance of the result or the positivity of the result, then with treatment effect on the x axis and sample size on the y axis, an inverted funnel should form. Asymmetries can but not necessarily are due to publication bias. Methods exist for determining those asymmetries. Assemble Results Use figures and tables to help present the studies included in the systematic review and their findings. A forest plots is the standard method of illustrating the results of both he individual studies and the meta-analysis. The RevMan software provided freely by the Cochrane Collaboration can generate these. 6
7 A summary-of-findings table provides the key information concerning the quality of the evidence, the size of the effect, and the sum of available data on important outcomes. See the next page for an example of a Summary of Findings table. Actually, the Cochrane Handbook provides the complete table from which this partial table is extracted. An Example of a Summary of Findings Table Compression stockings compared with no compression stockings for people taking long flights Patients or population: Anyone taking a long flight (lasting more than 6 hours) Settings: International air travel Intervention: Compression stockings Comparison: Without stockings Outcomes Illustrative comparative risks* (95% CI) Assumed risk Corresponding risk Relative effect (95% CI) Number of participants (studies) Quality of the evidence (GRADE) Comments Without stockings With stockings Symptomatic deep vein thrombosis (DVT) See comment See comment Not estimable 2821 (9 studies) See comment 0 participants developed symptomatic DVT in these studies. Symptom-less Low risk population RR
8 deep vein thrombosis 10 per per 1000 (0 to 3) High risk population 30 per per 1000 (1 to 8) (0.04 to 0.26) (9 studies) High Superficial vein thrombosis 13 per per 1000 (2 to 15) RR 0.45 (0.18 to 1.13) 1804 (8 studies) +++Ο Moderate Oedema Post-flight values measured on a scale from 0, no oedema, to 10, maximum oedema. The mean oedema score ranged across control groups from 6 to 9. The mean oedema score in the intervention groups was on average 4.7 lower (95% CI 4.9 to 4.5) (6 studies) ++ΟΟ Low *The basis for the assumed risk is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the intervention group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio GRADE: GRADE Working Group grades of evidence (see explanations) Interpret Results and Draw Conclusions The Cochrane Collaboration provides a GRADE approach to rate the quality of each outcome, giving four levels of high, moderate, low, and very low. Do not describe the results simply in terms of the presence or absence of statistical significance but provide the central tendency as well as the confidence interval and exact P value. For clinical relevant results regarding benefits and harms, use Numbers Needed to Treat calculations and confidence intervals. Peer-reviewed journals recognize systematic reviews as original scientific contributions. The PRISMA criteria included in this syllabus provide a guide to insure that your manuscript means standard criteria for including important aspects of the systematic review. Exercise 5 Consider the control event rate and the experimental event rates for pharyngitis in examining two preventive strategies. The control event rate was 12%. The experimental event rate as 8%. Calculate the relative risk reductions, the absolute risk reduction, and the numbers needed to treat. 8
9 PRISMA Flow Chart Flow of information through the different phases of a systematic review Identification Screening # of records identified through database searching # of records after duplicates removed # of records screened # of additional records identified through other sources # of records excluded Eligibility # of full-text articles assessed for eligibility # of full-text articles excluded, with reasons Included # of studies included in qualitative synthesis # of studies included in quantitative synthesis (metaanalysis) PRISMA Checklist Checklist of items to include when reporting a systematic review or meta-analysis. Section/Topic # Checklist Item TITLE Title 1 Identify the report as a systematic review, meta-analysis, or both. ABSTRACT Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study 9
10 appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. INTRODUCTION Rationale 3 Describe the rationale for the review in the context of what is already known. Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). METHODS Protocol and registration Eligibility criteria Information sources Search 8 Study selection 9 Data collection process 10 Data items 11 Risk of bias in individual studies Summary measures Synthesis of results Risk of bias across studies Additional analyses RESULTS 12 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number. Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale. Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis). Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made. Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. 13 State the principal summary measures (e.g., risk ratio, difference in means) Study selection 17 Study characteristics Risk of bias within studies Results of individual studies Synthesis of results Risk of bias across studies Additional Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I 2 ) for each meta-analysis. Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies). Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified. Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. Present data on risk of bias of each study and, if available, any outcome-level assessment (see Item 12). For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot. Present results of each meta-analysis done, including confidence intervals and measures of consistency. 22 Present results of any assessment of risk of bias across studies (see Item 15). 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). analysis DISCUSSION Summary of 24 Summarize the main findings including the strength of evidence for each main 10
11 evidence Limitations 25 Conclusions 26 FUNDING Funding 27 outcome; consider their relevance to key groups (e.g., health care providers, users, and policy makers). Discuss limitations at study and outcome level (e.g., risk of bias), and at review level (e.g., incomplete retrieval of identified research, reporting bias). Provide a general interpretation of the results in the context of other evidence, and implications for future research. Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review The Cochrane Collaboration The Cochrane Collaboration is an international organization. Its primary aim is to help people make well-informed decisions about health care by preparing, maintaining and promoting the accessibility of systematic reviews of the evidence that underpins them. The Cochrane Collaboration was founded in It has grown to include over 15,000 contributors from more than 100 countries. The Cochrane Collaboration was named after British epidemiologist Archie Cochrane. Archie Cochrane once wrote, It is surely a great criticism of our profession that we have not organized a critical summary, by specialty or subspecialty, updated periodically, of all relevant randomized controlled trials. You can find the Collaboration s web pages at The Cochrane Handbook for Systematic Reviews of Interventions (the Handbook) provides guidance to authors for the preparation of Cochrane Intervention reviews (including Cochrane Overviews of reviews). Anyone can access the Handbook at Selected Readings Zaza S, Wright-De Aguero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH, Sosin DM, Anderson L, Carande-Kulis VG, Teutsch SM, Pappaioanou M, Task Force on Community Preventive Services Data Collection Instrument and Procedure for Systematic Reviews in the Guide to Community Preventive Services. Am J Prev Med 2000;18(1S): Greenhalgh T. How to read a paper: Papers that summarise other papers (systematic reviews and meta-analyses). BMJ 1997; 315: 672- Ndiaye SM. Hopkins DP. Smith SJ. Hinman AR. Briss PA. Task Force on Community Preventive Services. Methods for conducting systematic reviews of targeted vaccination strategies for the guide to community preventive services. American Journal of Preventive Medicine. 2005; 28: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009; doi: /j.jclinepi The Cochrane Collaboration. URL: Accessed November 22, The Cochrane Collaboration. JPT Higgins and S Green, eds. The Cochrane Handbook for Systematic Reviews of Interventions. Edition Updated March URL: Accessed November 22,
The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews
The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews David Moher 1, Alessandro Liberati 2, Douglas G Altman 3, Jennifer Tetzlaff 1 for the QUOROM Group
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Search terms*
Supplementary Figure S1. Search terms* *mh = exploded MeSH: Medical subject heading (Medline medical index term); tw = text word; pt = publication type; the asterisk (*) stands for any character(s) #1:
More informationTable S1- PRISMA 2009 Checklist
Table S1- PRISMA 2009 Checklist Section/topic TITLE # Checklist item Title 1 Identify the report as a systematic review, meta-analysis, or both. 1 ABSTRACT Structured summary 2 Provide a structured summary
More informationSystematic Review & Course outline. Lecture (20%) Class discussion & tutorial (30%)
Systematic Review & Meta-analysisanalysis Ammarin Thakkinstian, Ph.D. Section for Clinical Epidemiology and Biostatistics Faculty of Medicine, Ramathibodi Hospital Tel: 02-201-1269, 02-201-1762 Fax: 02-2011284
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationTraumatic brain injury
Introduction It is well established that traumatic brain injury increases the risk for a wide range of neuropsychiatric disturbances, however there is little consensus on whether it is a risk factor for
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationResults. NeuRA Hypnosis June 2016
Introduction may be experienced as an altered state of consciousness or as a state of relaxation. There is no agreed framework for administering hypnosis, but the procedure often involves induction (such
More informationWhat is the Cochrane Collaboration? What is a systematic review?
1 What is the Cochrane Collaboration? What is a systematic review? Archie Cochrane (1909-1988) It is surely a great criticism of our profession that we have not organised a critical summary, by specialty
More informationResults. NeuRA Treatments for internalised stigma December 2017
Introduction Internalised stigma occurs within an individual, such that a person s attitude may reinforce a negative self-perception of mental disorders, resulting in reduced sense of selfworth, anticipation
More informationCochrane Breast Cancer Group
Cochrane Breast Cancer Group Version and date: V3.2, September 2013 Intervention Cochrane Protocol checklist for authors This checklist is designed to help you (the authors) complete your Cochrane Protocol.
More informationMeta-analyses: analyses:
Meta-analyses: analyses: how do they help, and when can they not? Lee Hooper Senior Lecturer in research synthesis & nutrition l.hooper@uea.ac.uk 01603 591268 Aims Systematic Reviews Discuss the scientific
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationStandards for the reporting of new Cochrane Intervention Reviews
Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the reporting of new Cochrane Intervention Reviews 24 September 2012 Preface The standards below summarize proposed attributes
More informationSystematic Reviews and Meta- Analysis in Kidney Transplantation
Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT
More informationLearning from Systematic Review and Meta analysis
Learning from Systematic Review and Meta analysis Efficacy and Safety of Antiscabietic Agents: A Systematic Review and Network Meta analysis of Randomized Controlled Trials KUNLAWAT THADANIPON, MD 4 TH
More informationCochrane Bone, Joint & Muscle Trauma Group How To Write A Protocol
A p r i l 2 0 0 8 Cochrane Bone, Joint & Muscle Trauma Group How To Write A Protocol This booklet was originally produced by the Cochrane Renal Group to make the whole process of preparing a protocol as
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationEssential Skills for Evidence-based Practice Understanding and Using Systematic Reviews
J Nurs Sci Vol.28 No.4 Oct - Dec 2010 Essential Skills for Evidence-based Practice Understanding and Using Systematic Reviews Jeanne Grace Corresponding author: J Grace E-mail: Jeanne_Grace@urmc.rochester.edu
More informationResults. NeuRA Forensic settings April 2016
Introduction Prevalence quantifies the proportion of individuals in a population who have a disease during a specific time period. Many studies have reported a high prevalence of various health problems,
More informationDistraction techniques
Introduction are a form of coping skills enhancement, taught during cognitive behavioural therapy. These techniques are used to distract and draw attention away from the auditory symptoms of schizophrenia,
More informationComponent of CPG development ILAE Recommendation Document Identifying topic and developing clinical. S3 research question
S1: Summary of recommendations for developing Clinical Practice Guidelines Minimum CPG development requirements (where resources are more limited) are bolded. When full resources are available, every recommendation
More informationAnimal-assisted therapy
Introduction Animal-assisted interventions use trained animals to help improve physical, mental and social functions in people with schizophrenia. It is a goal-directed intervention in which an animal
More informationControlled Trials. Spyros Kitsiou, PhD
Assessing Risk of Bias in Randomized Controlled Trials Spyros Kitsiou, PhD Assistant Professor Department of Biomedical and Health Information Sciences College of Applied Health Sciences University of
More informationStandards for the conduct and reporting of new Cochrane Intervention Reviews 2012
Methodological Expectations of Cochrane Intervention Reviews (MECIR) s for the conduct and reporting of new Cochrane Intervention Reviews 2012 Booklet Version 2 September 2013 1 Preface Cochrane Reviews
More informationSchool of Dentistry. What is a systematic review?
School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical
More informationResults. NeuRA Mindfulness and acceptance therapies August 2018
Introduction involve intentional and non-judgmental focus of one's attention on emotions, thoughts and sensations that are occurring in the present moment. The aim is to open awareness to present experiences,
More informationCONSORT 2010 checklist of information to include when reporting a randomised trial*
CONSORT 2010 checklist of information to include when reporting a randomised trial* Section/Topic Title and abstract Introduction Background and objectives Item No Checklist item 1a Identification as a
More informationEffect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A
Supplementary Information for: Effect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A Systematic Review and Meta-Analysis of Animal Studies Running title: Intermittent vs. chronic
More informationResults. NeuRA Motor dysfunction April 2016
Introduction Subtle deviations in various developmental trajectories during childhood and adolescence may foreshadow the later development of schizophrenia. Studies exploring these deviations (antecedents)
More informationMethodological standards for the conduct of new Cochrane Intervention Reviews Version 2.1, 8 December 2011
Methodological Expectations of Cochrane Intervention Reviews (MECIR) Methodological standards for the conduct of new Cochrane Intervention Reviews Version 2.1, 8 December 2011 Jackie Chandler, Rachel Churchill,
More informationGRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2018
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2018 Previous grading system Level of evidence Strength of recommendation Level of evidence
More informationEvidence-Based Medicine and Publication Bias Desmond Thompson Merck & Co.
Evidence-Based Medicine and Publication Bias Desmond Thompson Merck & Co. Meta-Analysis Defined A meta-analysis is: the statistical combination of two or more separate studies In other words: overview,
More informationMeta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014
Meta Analysis David R Urbach MD MSc Outcomes Research Course December 4, 2014 Overview Definitions Identifying studies Appraising studies Quantitative synthesis Presentation of results Examining heterogeneity
More informationNetwork Meta-Analysis of the Efficacy of Acupuncture, Alpha-blockers and Antibiotics on
Network Meta-Analysis of the Efficacy of Acupuncture, Alpha-blockers and Antibiotics on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Zongshi Qin, Jiani Wu, Jinhui Tian, Jing Zhou, Yali Liu, Zhishun
More informationAlcohol interventions in secondary and further education
National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods
More informationDownloaded from:
Arnup, SJ; Forbes, AB; Kahan, BC; Morgan, KE; McKenzie, JE (2016) The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials,
More informationFree Will and Agency: A Scoping Review and Map
Kent State University From the SelectedWorks of Paul Fehrmann Summer August 6, 2015 Free Will and Agency: A Scoping Review and Map Paul Fehrmann, Kent State University - Kent Campus Available at: https://works.bepress.com/paul_fehrmann/9/
More informationTranscranial Direct-Current Stimulation
Introduction (tdcs) is a non-invasive form of brain stimulation similar to transcranial magnetic stimulation, but instead of using magnets, it uses a lowintensity, constant current applied through scalp
More informationResults. NeuRA Treatments for dual diagnosis August 2016
Introduction Many treatments have been targeted to improving symptom severity for people suffering schizophrenia in combination with substance use problems. Studies of dual diagnosis often investigate
More informationResults. NeuRA Family relationships May 2017
Introduction Familial expressed emotion involving hostility, emotional over-involvement, and critical comments has been associated with increased psychotic relapse in people with schizophrenia, so these
More informationGATE CAT Intervention RCT/Cohort Studies
GATE: a Graphic Approach To Evidence based practice updates from previous version in red Critically Appraised Topic (CAT): Applying the 5 steps of Evidence Based Practice Using evidence about interventions
More informationMethodological standards for the conduct of new Cochrane Intervention Reviews Version 2.3, 02 December 2013
Methodological Expectations of Cochrane Intervention Reviews (MECIR) Methodological standards for the conduct of new Cochrane Intervention Reviews Version 2.3, 02 December 2013 Jackie Chandler, Rachel
More informationNeuRA Sleep disturbance April 2016
Introduction People with schizophrenia may show disturbances in the amount, or the quality of sleep they generally receive. Typically sleep follows a characteristic pattern of four stages, where stage
More informationDeterminants of quality: Factors that lower or increase the quality of evidence
Determinants of quality: Factors that lower or increase the quality of evidence GRADE Workshop CBO, NHG and Dutch Cochrane Centre CBO, April 17th, 2013 Outline The GRADE approach: step by step Factors
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Prophylactic cranial irradiation in patients with non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled
More information[population] or for TREATMENT: [Intervention or intervention contrast] for [health problem] in [population] Review information
Model Review (Version 1.0): for PREVENTION: [Intervention] for prevention of [health... Page 1 of 28 Model Review (Version 1.0): for PREVENTION: [Intervention] for prevention of [health problem] in [population]
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,
More informationUSDA Nutrition Evidence Library: Systematic Review Methodology
USDA Nutrition Evidence Library: Systematic Review Methodology Julie E. Obbagy, PhD, RD USDA Center for Nutrition Policy & Promotion Meeting #2 October 17, 2016 The National Academies of Sciences, Engineering,
More informationGuidelines for Writing and Reviewing an Informed Consent Manuscript From the Editors of Clinical Research in Practice: The Journal of Team Hippocrates
Guidelines for Writing and Reviewing an Informed Consent Manuscript From the Editors of Clinical Research in Practice: The Journal of Team Hippocrates 1. Title a. Emphasize the clinical utility of the
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first
More informationNeuRA Obsessive-compulsive disorders October 2017
Introduction (OCDs) involve persistent and intrusive thoughts (obsessions) and repetitive actions (compulsions). The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines
More informationDeep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein
More informationNeuRA Decision making April 2016
Introduction requires an individual to use their knowledge and experience of a context in order to choose a course of action 1. A person s ability to autonomously make decisions is referred to as their
More informationEvidence tabellen thema Interventies: Preventie van angst bij jeugdigen en niveau van bewijsvoering
Evidence tabellen thema Interventies: Preventie van angst bij jeugdigen en niveau van bewijsvoering In deze evidence tabellen word de drie meta analyses en systematische reviews beschreven die in dit hoofdstuk
More informationIntroduction to systematic reviews/metaanalysis
Introduction to systematic reviews/metaanalysis Hania Szajewska The Medical University of Warsaw Department of Paediatrics hania@ipgate.pl Do I needknowledgeon systematicreviews? Bastian H, Glasziou P,
More informationClinical research in AKI Timing of initiation of dialysis in AKI
Clinical research in AKI Timing of initiation of dialysis in AKI Josée Bouchard, MD Krescent Workshop December 10 th, 2011 1 Acute kidney injury in ICU 15 25% of critically ill patients experience AKI
More informationMethod. NeuRA Biofeedback May 2016
Introduction is a technique in which information about the person s body is fed back to the person so that they may be trained to alter the body s conditions. Physical therapists use biofeedback to help
More informationResults. NeuRA Herbal medicines August 2016
Introduction have been suggested as a potential alternative treatment which may positively contribute to the treatment of schizophrenia. Herbal therapies can include traditional Chinese medicines and Indian
More informationCritical appraisal: Systematic Review & Meta-analysis
Critical appraisal: Systematic Review & Meta-analysis Atiporn Ingsathit MD.PhD. Section for Clinical Epidemiology and biostatistics Faculty of Medicine Ramathibodi Hospital Mahidol University What is a
More informationDeveloping a research question The research question
Developing a research question The research question The research question for a systematic review should specify the types of population (participants), types of interventions (and comparisons), and the
More informationWebinar 3 Systematic Literature Review: What you Need to Know
Webinar 3 Systematic Literature Review: What you Need to Know Camille Kolotylo RN, PhD Andrea Baumann RN, PhD Nursing Health Services Research Unit (NHSRU) McMaster University Date: Thursday May 29, 2014
More informationSystematic Reviews and Meta-analysis in Aquatic therapy
Systematic Reviews and Meta-analysis in Aquatic therapy Prof. Daniel Daly Ben Waller PT, MSc 2nd European Congress on Evidence Based Aquatic Therapy Wednesday 15th April 2015 Systematic Review A systematic
More informationData extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.
Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives
More informationTemplate for MECIR (Review)
Template for MECIR (Review) This guidance document contains information regarding the Cochrane Collaboration's mandatory MECIR Conduct and Reporting Standards and editorial suggestions specific to PaPaS,
More informationFeng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor
Feng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor Department of Nursing, Central Taiwan University of Science
More informationNeuRA Schizophrenia diagnosis May 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationSYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS
SYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS A Case Study By Anil Khedkar, India (Masters in Pharmaceutical Science, PhD in Clinical Research Student of Texila American University)
More informationTiago Villanueva MD Associate Editor, The BMJ. 9 January Dear Dr. Villanueva,
Tiago Villanueva MD Associate Editor, The BMJ 9 January 2018 Dear Dr. Villanueva, Thank you for your thoughtful re-review of our Manuscript (BMJ.2017.041528) entitled "Immune-related Toxicities in PD-1
More informationGATE CAT Diagnostic Test Accuracy Studies
GATE: a Graphic Approach To Evidence based practice updates from previous version in red Critically Appraised Topic (CAT): Applying the 5 steps of Evidence Based Practice Using evidence from Assessed by:
More informationDatabase of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York.
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults Briss P A, Rodewald L E, Hinman A R, Shefer A M, Strikas R A, Bernier R R, Carande-Kulis
More informationInstrument for the assessment of systematic reviews and meta-analysis
Appendix II Annex II Instruments for the assessment of evidence As detailed in the main body of the methodological appendix (Appendix II, "Description of the methodology utilised for the collection, assessment
More informationPost-traumatic stress disorder
National Institute for Health and Care Excellence Final Post-traumatic stress disorder Methods NICE guideline NG116 Supplement 1 December 2018 Final These evidence reviews were developed by the National
More informationRecent developments for combining evidence within evidence streams: bias-adjusted meta-analysis
EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard
More informationTitle: Reporting and Methodologic Quality of Cochrane Neonatal Review Group Systematic Reviews
Reviewer's report Title: Reporting and Methodologic Quality of Cochrane Neonatal Review Group Systematic Reviews Version: 1 Date: 26 August 2008 Reviewer: Andreas Lundh Reviewer's report: General The authors
More informationAppendix Document A1: Search strategy for Medline (1960 November 2015)
Appendices: Appendix Document A1: Search strategy for Medline (1960 November 2015) Appendix Table A1: Detailed Risk of Bias Table Appendix Figure A1: Funnel plot Appendix Figure A2: Sensitivity analysis
More informationThe moderating impact of temporal separation on the association between intention and physical activity: a meta-analysis
PSYCHOLOGY, HEALTH & MEDICINE, 2016 VOL. 21, NO. 5, 625 631 http://dx.doi.org/10.1080/13548506.2015.1080371 The moderating impact of temporal separation on the association between intention and physical
More informationDatabase of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown
More informationCEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews
CEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews Since September 2013, the CEU has been responsible for pre-publication screening of new intervention
More informationWorkshop: Cochrane Rehabilitation 05th May Trusted evidence. Informed decisions. Better health.
Workshop: Cochrane Rehabilitation 05th May 2018 Trusted evidence. Informed decisions. Better health. Disclosure I have no conflicts of interest with anything in this presentation How to read a systematic
More informationA protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analyses
Systematic Reviews This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. A protocol for a systematic
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Drug-eluting balloon angioplasty versus non-stenting balloon angioplasty for peripheral arterial disease of the lower limbs [Cochrane Protocol]
More informationUses and misuses of the STROBE statement: bibliographic study
Uses and misuses of the STROBE statement: bibliographic study Bruno R. da Costa 1, Myriam Cevallos 1, 2, Douglas G. Altman 3, Anne W.S. Rutjes 1, Matthias Egger 1 1. Institute of Social & Preventive Medicine
More informationAppendices. Appendix A Search terms
Appendices Appendix A Search terms Database Search terms Medline 1. Ipilimumab; 2. MDX-010; 3. MDX-101; 4. Yervoy; 5. BMS-734016; 6. Nivolumab; 7. ONO-4538; 8. BMS-936558; 9. MDX-1106; 10. Opdivo; 11.
More informationSystematic reviews and meta-analyses are essential tools. Academia and Clinic
Annals of Internal Medicine Academia and Clinic The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: and Elaboration Alessandro Liberati,
More informationSystematic Reviews. Simon Gates 8 March 2007
Systematic Reviews Simon Gates 8 March 2007 Contents Reviewing of research Why we need reviews Traditional narrative reviews Systematic reviews Components of systematic reviews Conclusions Key reference
More informationAppendix A: Literature search strategy
Appendix A: Literature search strategy The following databases were searched: Cochrane Library Medline Embase CINAHL World Health organisation library Index Medicus for the Eastern Mediterranean Region(IMEMR),
More informationResults. NeuRA Essential fatty acids August 2016
Introduction Alternative treatments are investigated as a possible replacement for antipsychotic medication, which can be associated with severe side effects. Alternative therapies may have less debilitating
More informationGATE CAT Case Control Studies
GATE: a Graphic Approach To Evidence based practice updates from previous version in red Critically Appraised Topic (CAT): Applying the 5 steps of Evidence Based Practice Using evidence about aetiology/risk/interventions
More informationOutcomes assessed in the review
The effectiveness of mechanical compression devices in attaining hemostasis after removal of a femoral sheath following femoral artery cannulation for cardiac interventional procedures Jones T Authors'
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews A systematic review of behaviour change interventions targeting physical activity, exercise and HbA1c in adults with type 2 diabetes Leah
More informationMeta-analysis: Methodology
Meta-analysis: Methodology Example: Assessment of cardiovascular safety profile of new generation BCR-ABL TKIs in patients with CML Haguet Hélène 04/03/2016 Meta-analysis = statistical combination of results
More informationAsthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review. Isaretta L. Riley, MD
Asthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review By Isaretta L. Riley, MD A Master s Paper submitted to the faculty of the University of North Carolina at
More informationMeta-Analysis. Zifei Liu. Biological and Agricultural Engineering
Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis
More informationCopyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD
GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD ASSISTANT PROFESSOR DEPARTMENT OF CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS, MCMASTER UNIVERSITY Nancy Santesso,
More informationMINDFULNESS-BASED INTERVENTIONS IN EPILEPSY
03 March 2016; v.1 MINDFULNESS-BASED INTERVENTIONS IN EPILEPSY AIM This review aimed to evaluate the effectiveness of mindfulness as a therapeutic intervention for people with epilepsy. METHODS Criteria
More informationRetrieving and appraising systematic reviews
Retrieving and appraising systematic reviews rslavik@interchange.ubc.ca Richard S. Slavik, Pharm.D. Pharmacotherapeutic Specialist Critical Care CSU Pharmaceutical Sciences Vancouver Hospital & Health
More informationCHECK-LISTS AND Tools DR F. R E Z A E I DR E. G H A D E R I K U R D I S TA N U N I V E R S I T Y O F M E D I C A L S C I E N C E S
CHECK-LISTS AND Tools DR F. R E Z A E I DR E. G H A D E R I K U R D I S TA N U N I V E R S I T Y O F M E D I C A L S C I E N C E S What is critical appraisal? Critical appraisal is the assessment of evidence
More informationThe Meta on Meta-Analysis. Presented by Endia J. Lindo, Ph.D. University of North Texas
The Meta on Meta-Analysis Presented by Endia J. Lindo, Ph.D. University of North Texas Meta-Analysis What is it? Why use it? How to do it? Challenges and benefits? Current trends? What is meta-analysis?
More information